文献速递心脑血管急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

重型颅脑创伤中高动脉氧分压与补氧治疗:CENTER-TBI与OzENTER-TBI研究的启示

High arterial oxygen levels and supplemental oxygen administration in traumatic brain injury: insights from CENTER-TBI and OzENTER-TBI.
PubMed 文献 · Intensive Care Med · 2022-10-20
一句话结论在CENTER-TBI队列中,ICU入住后7天内较高的PaO2和FiO2与6个月死亡率独立相关,脑损伤严重程度并未调节这一关系,提示对TBI氧疗需谨慎。

该研究为两项多中心前瞻性观察性队列(CENTER-TBI与OzENTER-TBI)的二次分析,纳入ICU收治并接受机械通气的TBI患者。CENTER-TBI队列1084例(11577次测量),55%预后不良,6个月随访死亡率26%。入住ICU后7天内较高的PaO2和FiO2与更高的死亡率独立相关;OzENTER-TBI队列(n=159)部分证实了死亡率升高的趋势。GFAP独立与死亡率和功能神经预后相关,但未调节高PaO2对结局的影响。

要点

  • CENTER-TBI队列中,ICU入住后7天内较高的PaO2和FiO2与6个月死亡率独立相关(1084例,55%预后不良,26%死亡)。
  • OzENTER-TBI队列(n=159)部分证实了死亡率升高的趋势,但因样本量有限未完全验证。
  • GFAP独立与死亡率和功能神经预后相关,但未调节高PaO2与6个月死亡率之间的独立关联。
  • 中位PaO2在各中心间波动于93–166 mmHg,提示各中心氧疗实践差异大。
  • 作者认为,至少这些发现支持在TBI中谨慎使用氧疗,尤其补氧滴定可立即在床旁实施。

适用人群与场景

  • CENTER-TBI与OzENTER-TBI两大多中心前瞻性观察性队列中,ICU收治并接受机械通气的TBI患者;CENTER-TBI队列1084例,OzENTER-TBI队列159例。
  • 原文指出这些发现可能不适用于FiO2和PaO2根据脑组织氧监测(PbtO2)水平滴定的患者。

研究设计与关键结果

  • 研究类型:两项多中心、前瞻性、观察性队列研究(欧洲与澳大利亚)的二次分析;CENTER-TBI队列1084例(11577次测量),55%预后不良,6个月随访死亡率26%;OzENTER-TBI队列n=159。
  • 中位PaO2在各中心间范围为93–166 mmHg。
  • CENTER-TBI队列中,ICU入住后前7天内较高的PaO2和FiO2与更高的死亡率独立相关;OzENTER-TBI队列部分证实了死亡率升高的趋势。
  • GFAP独立与死亡率和随访时功能神经预后相关,但未调节高PaO2对结局的影响,高PaO2仍与6个月死亡率独立相关。

证据类型、等级与局限

  • 证据类型:多中心前瞻性观察性队列研究的二次分析。
  • 局限:原文指出,由于样本量有限,这些发现在外部OzENTER-TBI队列中未完全验证;不能排除较高PaO2相关的更差结局是由于损伤更重或生理受损的患者使用了较高FiO2所致;这些发现可能不适用于FiO2和PaO2根据PbtO2水平滴定的患者。

对床旁实践的改变

  • 作者认为,至少这些发现支持在TBI中谨慎使用氧疗,尤其补氧滴定可立即在床旁实施。
  • 原文指出不能排除较高PaO2相关的更差结局是由于损伤更重或生理受损的患者使用了较高FiO2所致。
  • 原文指出这些发现可能不适用于FiO2和PaO2根据PbtO2水平滴定的患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: The effect of high arterial oxygen levels and supplemental oxygen administration on outcomes in traumatic brain injury (TBI) is debated, and data from large cohorts of TBI patients are limited. We investigated whether exposure to high blood oxygen levels and high oxygen supplementation is independently associated with outcomes in TBI patients admitted to the intensive care unit (ICU) and undergoing mechanical ventilation.

METHODS: This is a secondary analysis of two multicenter, prospective, observational, cohort studies performed in Europe and Australia. In TBI patients admitted to ICU, we describe the arterial partial pressure of oxygen (PaO2) and the oxygen inspired fraction (FiO2). We explored the association between high PaO2 and FiO2 levels within the first week with clinical outcomes. Furthermore, in the CENTER-TBI cohort, we investigate whether PaO2 and FiO2 levels may have differential relationships with outcome in the presence of varying levels of brain injury severity (as quantified by levels of glial fibrillary acidic protein (GFAP) in blood samples obtained within 24 h of injury).

RESULTS: The analysis included 1084 patients (11,577 measurements) in the CENTER-TBI cohort, of whom 55% had an unfavorable outcome, and 26% died at a 6-month follow-up. Median PaO2 ranged from 93 to 166 mmHg. Exposure to higher PaO2 and FiO2 in the first seven days after ICU admission was independently associated with a higher mortality rate. A trend of a higher mortality rate was partially confirmed in the OzENTER-TBI cohort (n = 159). GFAP was independently associated with mortality and functional neurologic outcome at follow-up, but it did not modulate the outcome impact of high PaO2 levels, which remained independently associated with 6-month mortality.

CONCLUSIONS: In two large prospective multicenter cohorts of critically ill patients with TBI, levels of PaO2 and FiO2 varied widely across centers during the first seven days after ICU admission. Exposure to high arterial blood oxygen or high supplemental oxygen was independently associated with 6-month mortality in the CENTER-TBI cohort, and the severity of brain injury did not modulate this relationship. Due to the limited sample size, the findings were not wholly validated in the external OzENTER-TBI cohort. We cannot exclude the possibility that the worse outcomes associated with higher PaO2 were due to use of higher FiO2 in patients with more severe injury or physiological compromise. Further, these findings may not apply to patients in whom FiO2 and PaO2 are titrated to brain tissue oxygen monitoring (PbtO2) levels. However, at minimum, these findings support the need for caution with oxygen therapy in TBI, particularly since titration of supplemental oxygen is immediately applicable at the bedside.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Rezoagli E, Petrosino M, Rebora P, et al. High arterial oxygen levels and supplemental oxygen administration in traumatic brain injury: insights from CENTER-TBI and OzENTER-TBI. Intensive Care Med. 2022. PMID: 36264365. doi:10.1007/s00134-022-06884-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。